Extraction of Bioactive Compounds for Antioxidant, Antimicrobial, and Antidiabetic Applications.
GC-MS
antidiabetic
antimicrobial
antioxidant
medicinal plants
Journal
Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009
Informations de publication
Date de publication:
13 Sep 2022
13 Sep 2022
Historique:
received:
13
08
2022
revised:
06
09
2022
accepted:
08
09
2022
entrez:
23
9
2022
pubmed:
24
9
2022
medline:
28
9
2022
Statut:
epublish
Résumé
This study was designed to check the potential of secondary metabolites of the selected plants; Citrullus colocynthis, Solanum nigrum, Solanum surattense, Calotropis procera, Agave americana, and Anagallis arvensis for antioxidant, antibacterial, antifungal, and antidiabetic agents. Plant material was soaked in ethanol/methanol to get the crude extract, which was further partitioned via solvent extraction technique. GCMS and FTIR analytical techniques were applied to check the compounds responsible for causing antioxidant, antimicrobial, and antidiabetic activities. It was concluded that about 80% of studied extracts/fractions were active against α-amylase, ranging from 43 to 96%. The highest activity (96.63%) was exhibited by butanol fractions of A. arvensis while the least response (43.65%) was shown by the aqueous fraction of C. colocynthis and the methanol fraction of fruit of S. surattense. The highest antioxidant activity was shown by the ethyl acetate fraction of Anagallis arvensis (78.1%), while aqueous as well as n-hexane fractions are the least active throughout the assay. Results showed that all tested plants can be an excellent source of natural products with potential antimicrobial, antioxidant, and antidiabetic potential. The biological response of these species is depicted as a good therapeutic agent, and, in the future, it can be encapsulated for drug discovery.
Identifiants
pubmed: 36144671
pii: molecules27185935
doi: 10.3390/molecules27185935
pmc: PMC9503716
pii:
doi:
Substances chimiques
Anti-Bacterial Agents
0
Anti-Infective Agents
0
Antifungal Agents
0
Antioxidants
0
Butanols
0
Hypoglycemic Agents
0
Plant Extracts
0
Solvents
0
Ethanol
3K9958V90M
alpha-Amylases
EC 3.2.1.1
Methanol
Y4S76JWI15
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : This work was supported by Al Bilad Bank Scholarly Chair for Food Security in Saudi Arabia: the Deanship of Scientific Research, Vice Presidency for Graduate Studies and Scientific Research, King Faisal University, Saudi Arabia
ID : [Project No. CHAIR38].
Références
J Evid Based Complementary Altern Med. 2017 Oct;22(4):944-955
pubmed: 29228789
Biomolecules. 2019 Sep 30;9(10):
pubmed: 31575072
Int J Ayurveda Res. 2010 Jan;1(1):14-7
pubmed: 20532092
Pharmacogn Rev. 2012 Jan;6(11):22-8
pubmed: 22654401
Med Sci (Basel). 2021 Mar 31;9(2):
pubmed: 33807402
PLoS Med. 2006 Nov;3(11):e442
pubmed: 17132052
J Steroid Biochem Mol Biol. 2010 Aug;121(3-5):496-504
pubmed: 20417277
J Ethnopharmacol. 2010 Mar 24;128(2):384-9
pubmed: 20100559
Molecules. 2021 Nov 26;26(23):
pubmed: 34885744
J Nat Prod. 2008 Aug;71(8):1427-30
pubmed: 18681481
Microorganisms. 2021 Sep 27;9(10):
pubmed: 34683362
J Agric Food Chem. 2004 Jun 16;52(12):4026-37
pubmed: 15186133
Pak J Pharm Sci. 2012 Jul;25(3):651-6
pubmed: 22713956
Microbiol Res. 2018 Oct;215:76-88
pubmed: 30172312
Antioxidants (Basel). 2022 Mar 29;11(4):
pubmed: 35453341
BMC Complement Altern Med. 2011 Jun 30;11:52
pubmed: 21718504
BMC Complement Altern Med. 2010 Jan 29;10:6
pubmed: 20109237
Nat Prod Res. 2018 Jun;32(11):1291-1294
pubmed: 28562078
Nat Prod Res. 2020 Feb;34(4):449-455
pubmed: 31135192
Pharm Biol. 2018 Dec;56(1):18-24
pubmed: 29233045
Pharmaceuticals (Basel). 2022 Jan 04;15(1):
pubmed: 35056122
Food Chem X. 2022 May 18;14:100334
pubmed: 35712535
Front Pharmacol. 2014 Jan 10;4:177
pubmed: 24454289